Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001945603-24-000001
Filing Date
2024-07-02
Accepted
2024-07-02 14:25:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2901
  Complete submission text file 0001945603-24-000001.txt   4443
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Subject) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36291 | Film No.: 241094351
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 301 CARLSON PARKWAY, SUITE 210 MINNEAPOLIS MN 55305
Business Address
Daves Julie VanOrsdel (Reporting) CIK: 0001945603 (see all company filings)

Type: 144